Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 381 participants.

Also called NCT02817776

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 381 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02817776
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02817776. Allocation not applicable; no masking; primary purpose treatment. Start 2016-06-01 (actual); primary completion 2019-06-05 (actual). Results posted on 2021-01-12.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF)
Acronym
PRECEPT
Intervention (Device)
THERMOCOOL SMARTTOUCH® SF catheter
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02817776
Content hash
52d0399b493b8c0fef15ca939cd9a65731a9d54cad2d299f5711bd9e8c4e2b58